Research graph
References from Plasma metabolomic and lipidomic profiling in early-stage psychosis. Local targets link to admitted publications; unresolved targets remain external evidence.
The scale for the assessment of negative symptoms (SANS): conceptual and theoretical foundations
10.1192/s0007125000291496 · 1989 · External reference
Positive and negative symptoms: assessment and validity
1991 · External reference
Characterization of antipsychotic medications, amino acid signatures, and platelet-activating factor in first-episode psychosis
2021 · External reference
Early intervention in psychosis. The critical period hypothesis
10.1192/s0007125000297663 · 1998 · External reference
A reproducibility crisis for clinical metabolomics studies
10.1016/j.trac.2024.117918 · 2024 · External reference
A systematic review of metabolite biomarkers of schizophrenia
10.1016/j.schres.2017.09.021 · 2018 · External reference
Soluble α2δ-1, altered in disease CSF, modulates network homeostasis and rescues deficits in a neuropsychiatric mouse model
10.1016/j.neuron.2026.02.004 · 2026 · External reference
The R package geepack for generalized estimating equations
2005 · External reference
CLN3 is required for the clearance of glycerophosphodiesters from lysosomes
10.1038/s41586-022-05221-y · 2022 · External reference
Dose equivalents for antipsychotic drugs: the DDD method
10.1093/schbul/sbv167 · 2016 · External reference
Discovery of lipid profiles in plasma-derived extracellular vesicles as biomarkers for breast cancer diagnosis
10.1111/cas.15935 · 2023 · External reference
A phenome-wide association study (PheWAS) to identify the health impacts of 4-cresol sulfate in the Nagahama Study
10.1038/s41598-023-40697-2 · 2023 · External reference
Early recovery in the first 24 months of treatment in first-episode schizophrenia-spectrum disorders
10.1038/s41537-019-0091-y · 2020 · External reference
Confirmatory factor analysis reveals a latent cognitive structure common to bipolar disorder, schizophrenia, and normal controls
10.1111/bdi.12075 · 2013 · External reference
Neuronal autophagy in synaptic functions and psychiatric disorders
10.1016/j.biopsych.2019.07.018 · 2020 · External reference
Lysosomal dysfunction in neurodegeneration: emerging concepts and methods
10.1016/j.tins.2021.12.004 · 2022 · External reference
Aberrant aging-associated p62 autophagic cascade in biopsied olfactory neuronal cells from patients with psychosis
10.1038/s41537-025-00617-x · 2025 · External reference
Angiotensin-converting enzyme in patients with early-stage psychosis
10.1001/jamapsychiatry.2026.2588 · 2026 · External reference
A multimodal study of a first episode psychosis cohort: potential markers of antipsychotic treatment resistance
10.1038/s41380-021-01331-7 · 2022 · External reference
Discovery of biological markers for schizophrenia based on metabolomics: a systematic review
10.3389/fpsyt.2025.1540260 · 2025 · External reference
Angiotensin-converting enzyme in patients with early-stage psychosis
10.1001/jamapsychiatry.2026.2588 · ExternalCitation · doi-reference
Neuronal autophagy in synaptic functions and psychiatric disorders
10.1016/j.biopsych.2019.07.018 · ExternalCitation · doi-reference
Soluble α2δ-1, altered in disease CSF, modulates network homeostasis and rescues deficits in a neuropsychiatric mouse model
10.1016/j.neuron.2026.02.004 · ExternalCitation · doi-reference
A systematic review of metabolite biomarkers of schizophrenia
10.1016/j.schres.2017.09.021 · ExternalCitation · doi-reference
Lysosomal dysfunction in neurodegeneration: emerging concepts and methods
10.1016/j.tins.2021.12.004 · ExternalCitation · doi-reference
A reproducibility crisis for clinical metabolomics studies
10.1016/j.trac.2024.117918 · ExternalCitation · doi-reference
A multimodal study of a first episode psychosis cohort: potential markers of antipsychotic treatment resistance
10.1038/s41380-021-01331-7 · ExternalCitation · doi-reference
Early recovery in the first 24 months of treatment in first-episode schizophrenia-spectrum disorders
10.1038/s41537-019-0091-y · ExternalCitation · doi-reference
Aberrant aging-associated p62 autophagic cascade in biopsied olfactory neuronal cells from patients with psychosis
10.1038/s41537-025-00617-x · ExternalCitation · doi-reference
CLN3 is required for the clearance of glycerophosphodiesters from lysosomes
10.1038/s41586-022-05221-y · ExternalCitation · doi-reference
A phenome-wide association study (PheWAS) to identify the health impacts of 4-cresol sulfate in the Nagahama Study
10.1038/s41598-023-40697-2 · ExternalCitation · doi-reference
Dose equivalents for antipsychotic drugs: the DDD method
10.1093/schbul/sbv167 · ExternalCitation · doi-reference
Confirmatory factor analysis reveals a latent cognitive structure common to bipolar disorder, schizophrenia, and normal controls
10.1111/bdi.12075 · ExternalCitation · doi-reference
Discovery of lipid profiles in plasma-derived extracellular vesicles as biomarkers for breast cancer diagnosis
10.1111/cas.15935 · ExternalCitation · doi-reference
The scale for the assessment of negative symptoms (SANS): conceptual and theoretical foundations
10.1192/s0007125000291496 · ExternalCitation · doi-reference
Early intervention in psychosis. The critical period hypothesis
10.1192/s0007125000297663 · ExternalCitation · doi-reference
Discovery of biological markers for schizophrenia based on metabolomics: a systematic review
10.3389/fpsyt.2025.1540260 · ExternalCitation · doi-reference
